For me it's been 3 grueling years holding this diamond in the rough/disaster. Fortunately I trimmed over half the position before the now infamous merger fiasco unraveled. Management's inability to understand and act upon the dynamics of the situation has left many disgruntled shareholders paying a heavy toll. If management gets booted then maybe one day we will finally produce some tangible results and we'll all be happy campers... that'll be the day, I truely wish that for all who've endured the pain. These days I hardly ever look to see what if anything that's going on with this company because rarely is there ever anything meaningful or good. Anyone here have information or insight as to what's actually going on within the walls of MYRX and what we can expect by years end?
The most likely subjects of news before year-end would be the two pro-drugs. It is possible that there could be a very limited cooperation agreement in the IKke program in that time frame. There is a very small chance that one of the candidates could be sold outright (Management probably wouldn't be interested unless the price was high enough to pay for a study of drug combinations including Azixa against a 'Big 4' cancer). It is possible that the patient with an apparent complete response in the most recently reported Azixa study may be reclassified in the official results (for technical reasons that I don't understand he's considered a non-responder).
I know not what is going on inside only that this has been heavily manipulated the past couple months (reason??), solid pipe and tons of cash, rare for a stock of this type, accumulate way below book at current levels for one of best values in the sector. Patience is needed here.